Notably, BAFF demonstrates diagnostic utility, achieving 75.0% sensitivity and 71.4% specificity in identifying CAD patients with high SYNTAX scores, and 75.5% sensitivity with 72.8% specificity for stratifying AMI patients with elevated GRACE risk scores (274). The gene discussed is TNFSF13B; the disease is coronary artery disorder.